NCT04305145 2026-01-29
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Massachusetts General Hospital
Phase 2 Active not recruiting
Clinical Trials
1 trialsActive not recruiting × Drug-Related Side Effects and Adverse Reactions × Methylprednisolone Hemisuccinate × Clear all